News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Guyer Charles Greg
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 5,360 shares
@ $93.304, valued at
$500.1k
|
|
08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/08/2023 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 239 shares
@ $66.88, valued at
$16k
Paid exercise price by delivering 4,302 shares
@ $95.45, valued at
$410.6k
|
|
03/17/2023 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 8,900 shares
@ $0 Paid exercise price by delivering 1,856 shares
@ $87.74, valued at
$162.8k
Granted 20,320 options to buy
@ $87.74, valued at
$1.8M
|
|
02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 243 shares
@ $62.407, valued at
$15.2k
Paid exercise price by delivering 3,926 shares
@ $84.65, valued at
$332.3k
|
|
03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2022 |
5
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2020 |
4
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 35,040 shares
@ $0 Granted 64,150 options to buy
@ $90.36, valued at
$5.8M
|
|
05/06/2020 |
3
| Guyer Charles Greg (EVP, Chief Technical Officer) has filed a Form 3 on BIOMARIN PHARMACEUTICAL INC |
|
|